Biogen Idec, the company behind several of today’s most widely sold multiple sclerosis drugs, has been developing a…
Articles by Ana de Barros, PhD
A large study entitled “Genome-wide studies of verbal declarative memory in non-demented older people: the CHARGE…
The Texas A&M Health Science Center College of Medicine recently launched a new initiative against Alzheimer’s Disease that aims to encourage…
In a new study entitled “Metabotropic P2Y1 receptor signaling mediates astrocytic hyperactivity in vivo in an Alzheimer’s disease…
Biopharmaceutical company Anavex Life Sciences Corp. recently presented encouraging results from their phase 1 clinical trial, a…
A recent review from Schichun Tu and colleagues entitled “Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease”…
The Alzheimer’s Foundation of America (AFA) is organizing a public awareness campaign to remember the importance of keeping memories alive.
In a research article entitled “Primary age-related…
The Cigna Foundation announced that is awarding a $196,000 World of Difference grant to the Alzheimer’s Association to…
A novel, potentially disease-modifying treatment for Alzheimer’s disease is set to begin a Phase 2a…